1. Home
  2. VANI vs GCTS Comparison

VANI vs GCTS Comparison

Compare VANI & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • GCTS
  • Stock Information
  • Founded
  • VANI 1998
  • GCTS 1998
  • Country
  • VANI United States
  • GCTS United States
  • Employees
  • VANI N/A
  • GCTS N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GCTS Blank Checks
  • Sector
  • VANI Health Care
  • GCTS Finance
  • Exchange
  • VANI Nasdaq
  • GCTS Nasdaq
  • Market Cap
  • VANI 81.2M
  • GCTS 82.1M
  • IPO Year
  • VANI 2014
  • GCTS N/A
  • Fundamental
  • Price
  • VANI $1.61
  • GCTS $1.45
  • Analyst Decision
  • VANI Strong Buy
  • GCTS Strong Buy
  • Analyst Count
  • VANI 1
  • GCTS 1
  • Target Price
  • VANI $4.00
  • GCTS $5.00
  • AVG Volume (30 Days)
  • VANI 484.1K
  • GCTS 371.5K
  • Earning Date
  • VANI 11-13-2025
  • GCTS 11-12-2025
  • Dividend Yield
  • VANI N/A
  • GCTS N/A
  • EPS Growth
  • VANI N/A
  • GCTS N/A
  • EPS
  • VANI N/A
  • GCTS N/A
  • Revenue
  • VANI N/A
  • GCTS $6,073,000.00
  • Revenue This Year
  • VANI N/A
  • GCTS N/A
  • Revenue Next Year
  • VANI N/A
  • GCTS $1,597.96
  • P/E Ratio
  • VANI N/A
  • GCTS N/A
  • Revenue Growth
  • VANI N/A
  • GCTS N/A
  • 52 Week Low
  • VANI $0.91
  • GCTS $0.90
  • 52 Week High
  • VANI $1.92
  • GCTS $2.86
  • Technical
  • Relative Strength Index (RSI)
  • VANI 53.84
  • GCTS 48.13
  • Support Level
  • VANI $1.59
  • GCTS $1.41
  • Resistance Level
  • VANI $1.81
  • GCTS $1.75
  • Average True Range (ATR)
  • VANI 0.15
  • GCTS 0.10
  • MACD
  • VANI 0.00
  • GCTS 0.00
  • Stochastic Oscillator
  • VANI 49.18
  • GCTS 23.08

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About GCTS GCT Semiconductor Holding Inc. Common Stock

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

Share on Social Networks: